Kathmandu – Similar to the havoc caused by COVID-19, the HMPV (Human Metapneumovirus) has been reported in India, a neighboring country of Nepal. Out of the eight reported cases in India, six were found in infants under the age of one, with the remaining two cases involving children aged 7 and 13 years.
The symptoms of this respiratory illness are akin to the common cold or flu. However, in some cases, the symptoms can escalate to those resembling bronchitis or pneumonia. Infants, young children, the elderly, and individuals with compromised immune systems are at greater risk.
Let’s delve into how vulnerable children are to HMPV and why.
Why Are Infants More Vulnerable?
According to Dr. R.D. Srivastava, a senior consultant in neonatology and pediatric care in Delhi, newborns are at a higher risk of HMPV infection. Globally, data shows that most HMPV cases occur in infants aged 4 to 6 months. Similarly, in India, the majority of cases have been observed in children under one year of age.
Although adults in China have also been reported to contract HMPV, a weakened immune system remains the biggest contributing factor.
Recognizing the Symptoms of HMPV
HMPV infection manifests with symptoms similar to those of other viral infections. Therefore, it is crucial not to ignore signs of a cold, cough, or fever in young children. Consult a doctor if respiratory problems arise, as these could indicate an HMPV infection.
Dr. Ankit Bansal, an internal medicine and infectious disease consultant, states that while the virus has undergone mutations, it is not yet confirmed whether these mutations are more dangerous. Therefore, there is no immediate cause for alarm.
The Indian government has also clarified in a review meeting that HMPV is not a new virus. While it was not prevalent in India and other countries for years, no severe cases have been reported thus far.
Seasonal Risk Factors
According to a study published in the Journal of Allergy and Clinical Immunology, respiratory infections are more prevalent during colder months. Therefore, if symptoms similar to the flu appear, remain calm but cautious. Ignoring the symptoms entirely is not advisable; seeking medical advice is the best course of action.
Prevention Is Key
Currently, there is no antibiotic, antiviral drug, or vaccine available to combat HMPV. Prevention is the only effective strategy. Families with infants should exercise extra care.
Similar to COVID-19, HMPV spreads through contact with infected individuals. Shaking hands with an infected person or touching contaminated objects can also transmit the virus. Thus, maintaining hygiene and washing hands frequently are the primary ways to prevent HMPV.
Common Questions About HMPV
1. Can HMPV be fatal for children?
Yes, HMPV can be fatal in rare cases. However, globally, the virus accounts for less than 1% of deaths. There is no reason to panic.
2. Are children facing severe complications due to HMPV?
Not usually. Young children are more prone to infections due to their underdeveloped immune systems. However, only children with weak lungs tend to develop complications. Most infected children exhibit symptoms similar to the common cold.
3. Is oxygen therapy necessary for infected children?
No, oxygen therapy is only required for children with pneumonia caused by HMPV. At present, there is no cause for concern. However, children with significantly weakened immune systems need extra care.
4. Besides young children, who else should take precautions?
Infants under one year and the elderly are most vulnerable to HMPV. Infants have underdeveloped immune systems, while the immune strength of the elderly declines with age. Therefore, these groups are at the highest risk of HMPV infection.
Final Thoughts
While HMPV has similarities to the common cold, it can pose a significant risk to vulnerable groups. Maintaining good hygiene, being vigilant about symptoms, and seeking medical advice when necessary can help protect against this virus. Prevention remains the best defense.
Post a Comment